Wednesday, July 8, 2026

Patent directory · USPTO A61K / A61P

Patents matching “GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD.”

11 pharma patents match "GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 11
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 11 pharmaceutical patents matching "GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

11 results for “GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD.” · 30,257 patents in full index Clear search

  1. US 12377151

    Immobilized endoglycosidase fusion protein and use thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Aug 5, 2025 · Expires Jul 31, 2045

    granted
  2. US 12318457

    Oligosaccharide linker, linker-payload comprising the same and glycan chain-remodeled antibody-drug conjugate, preparation methods and uses thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Jun 3, 2025 · Expires May 29, 2045

    granted
  3. US 11999748

    Exatecan derivatives, linker-payloads, and conjugates and thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Jun 4, 2024 · Expires May 30, 2044

    granted
  4. US 11911434

    Stable antibody-drug conjugate, preparation method therefor, and use thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Feb 27, 2024 · Expires Feb 22, 2044

    granted
  5. US 11911435

    Stable antibody-drug conjugate, preparation method therefor, and use thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Feb 27, 2024 · Expires Feb 22, 2044

    granted
  6. US 11834688

    Ligase fusion proteins and application thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Dec 5, 2023 · Expires Nov 30, 2043

    granted
  7. US 11826432

    Linkers, conjugates and applications thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Nov 28, 2023 · Expires Nov 23, 2043

    granted
  8. US 11814394

    Exatecan derivatives, linker-payloads, and conjugates and thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Nov 14, 2023 · Expires Nov 9, 2043

    granted
  9. US 11717576

    Antibody-immune agonist conjugate and applications thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Aug 8, 2023 · Expires Aug 3, 2043

    granted
  10. US 11453870

    Ligase fusion proteins and application thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted
  11. US 11040084

    Stable antibody-drug conjugate, preparation method therefor, and use thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Jun 22, 2021 · Expires Jun 17, 2041

    granted